Since BChE has been associated with malnutrition, chronic inflammation, and impaired liver function, as well as advanced tumor stage, it is a promising prognostic tool to consider during decision-making for treatment regimes in oncologic patients. The gene discussed is BCHE; the disease is inflammatory response.